
Journal Menu
► ▼ Journal Menu-
- Brain Sciences Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
30 April 2025
Richard DiMarchi and Rolf Müller Share the 2024 Tu Youyou Award

We are pleased to announce that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.
![]() Richard DiMarchi Indiana University, USA |
Prof. Richard DiMarchi is a Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University, USA. He is a member of the National Academy of Medicine and the National Inventors Hall of Fame. Dr. DiMarchi is a former Group Vice President at Eli Lilly and later at Novo Nordisk. He is recognized for his contributions to the discovery and development of rDNA-derived Humulin®, Humalog®, rGlucagon®, and Forteo®. His academic research has broadened the understanding of glucagon and incretin physiology and pioneered the discovery of single-molecule multi-mechanism agonists for the treatment of diabetes and obesity. The central element to success has been the chemical vision and technology to install within single molecules simultaneous agonism at related G-protein coupled receptors, coupled to the counter-intuitive discovery that glucagon and GIP agonism could synergize the therapeutic efficacy of GLP-1. These peptides and their conceptual approach have transformed the management of excessive body weight to a condition comparable to how hypertension, adult-onset diabetes, and excess cholesterol are medicinally managed. |
“Professor DiMarchi was recognized by the 2024 Tu Youyou Award Committee members as being an exceptional leader in the medicinal chemistry of peptides and proteins of natural origin, and as a pioneer in the field of chemical biotechnology. His very important discoveries have led to breakthroughs in new drugs related to the therapy of diabetes and obesity. He has been named as an inventor on a very large number of patents, and he has had initially a highly successful scientific and administrative career in industry, which was followed by over two decades in academia as a distinguished professor.” —Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee |
|
![]() Rolf Müller Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany; Helmholtz Centre for Infections Research (HZI), Germany; Saarland University, Germany |
Prof. Rolf Müller is the Founding and Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biotechnology at Saarland University, Germany. Having received his training from the University of Bonn, he held research positions at the University of Washington, USA, and Braunschweig University of Technology, Germany, prior to his appointment as professor to Saarland University. His laboratory has dedicated itself to the exploration of bacterial natural-product biosynthetic pathways for more than 20 years and has extensive experience in working with myxobacteria and other microbial producer strains. Starting from the isolation and characterization of new microorganisms, the scope of work includes microbiology-, biotechnology-, bioinformatics-, and chemistry-based approaches to exploit these isolates as sources of new drugs with a special focus on novel anti-infectives. Müller and his team apply a variety of state-of-the-art analytical methods and biological assays to perform biological and chemical characterizations of the identified compounds. Prof. Müller has received several awards, including the prestigious Gottfried Wilhelm Leibniz Prize, the PHOENIX Pharmacy Research Award, the DECHEMA Prize, and the Inhoffen Medal, as well as being an elected member of acatech, Leopoldina, and the German Academy of Sciences and Literature. |
“The 2024 Tu Youyou Award Committee members were highly impressed by the truly outstanding past and ongoing contributions of Professor Müller in both microbial natural products isolation chemistry and in biosynthesis, as well as in the development of lead compounds for their potential in treating human diseases, through his global connections with various major funding agencies. He is also a dedicated teacher who has trained numerous graduate students and postdoctoral fellows, and he has lectured on his research in countries all over the world.” —Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee |
The achievements of Richard DiMarchi and Rolf Müller highlight the transformative impact of natural products chemistry and medicinal chemistry. We congratulate them and invite the global academic community and public to join us in celebrating their significant contributions.
2024 Award Committee
Committee Chair:
- Prof. Dr. A. Douglas Kinghorn, Ohio State University, USA.
Committee Members (listed in alphabetical order):
- Prof. Angelo Fontana, University of Naples “Federico II”, Italy;
- Prof. Binghe Wang, Georgia State University, USA;
- Dr. Diana Pinto, University of Aveiro, Portugal;
- Prof. Hideaki Kakeya, Kyoto University, Japan;
- Dr. RuAngelie Edrada-Ebel, University of Strathclyde, UK;
- Prof. Thomas Prisinzano, University of Kentucky, USA
- Prof. Wei Li, University of Tennessee Health Science Center, USA.
About the Tu Youyou Award:
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honor the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award honoring exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.
For further information about the award and the winners, please visit the Tu Youyou Award website.
30 April 2025
MDPI INSIGHTS: The CEO's Letter #22 - 300 Journals in WoS, Norway & Sweden Consortiums, Self-citations

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Over 300 MDPI Journals are Indexed in Web of Science
Indexing is essential to scholarly publishing as it promotes visibility and the impact of research. I’m excited to share that MDPI now has over 300 journals indexed in the Web of Science (WoS). This milestone reflects the work of our authors, editors, reviewers, and the entire MDPI staff, contributing to greater visibility and impact for open access research.
Publish with MDPI, publish with impact.
Having over 300 MDPI journals indexed in the Web of Science is more than a numbers game. It represents a recognition of the quality, consistency, and relevance of the research published in our journals. For the academic community, it reflects the growing trust in MDPI as a reputable publisher, leading the way in open access publishing.
A closer look at the achievement
Being indexed in the WoS nvolves meeting a list of quality criteria, including 24 quality benchmarks for ESCI journals.
For MDPI, rigorous editorial standards and scientific integrity are key. These enabled over 300 journals to pass the Web of Science quality criteria for indexing.
Here we share a blog post discussing the importance of this milestone for MDPI and open scholarly research. In this post, Constanze Schelhorn, Head of Indexing, at MDPI, and Giulia Stefenelli, Scientific Communications Lead, share their thoughts and insights on what this achievement means for our commitment to high-quality research.
“MDPI has a well-structured quality assurance framework that applies to all our journals. We also apply clear, standardized peer-review policies across our portfolio, ensuring transparency and consistency.” – Constanze Schelhorn, Head of Indexing
“This achievement is a step forward for Open Access research, reinforcing the mission to share scientific knowledge globally and facilitate research progress.” – Giulia Stefenelli, Scientific Communications Lead
Read the blog here: https://blog.mdpi.com/2025/04/03/300-mdpi-journals/
Looking to the future
This milestone is a testament to MDPI’s dedication to peer review, editorial excellence, and innovation in academic publishing. It highlights our role as leaders in open access publishing.
Personally, I see this as just the beginning. We will continue to support researchers, expand our contributions to scholarly communication, and push the boundaries of academic publishing.
Impactful Research
Nearly 920 partner institutions in MDPI’s Institutional Open Access Program
I’m pleased to share some exciting progress from MDPI's Institutional Open Access Program (IOAP), which now includes nearly 920 partner institutions worldwide. This is more than just a number. It reflects the growing trust and collaboration we’ve built with universities, libraries, and research organizations across the globe.
The IOAP offers institutions discounted Article Processing Charges (APCs), access to a dedicated institutional dashboard, and transparency throughout the publishing process.
Norway’s Sikt Consortium Renews national agreement with MDPI
MDPI has renewed its national agreement with the Sikt Consortium, which now supports 36 institutions across Norway. New partners, such as Kristiania University of Applied Sciences, join long-standing collaborators such as NTNU, the University of Bergen, and UiT, The Arctic University of Norway. The agreement promotes affordable, high-quality open access publishing through centralized APC funding, and reinforces Norway’s leadership in open science.
These agreements reflect MDPI’s mission to remove barriers to scientific publishing and make research freely available to all. By collaborating with national consortia and institutions, we advance the open access and strengthen our global network and collaborations.
Our IOAP Team
A big thank-you to our IOAP team for driving these important collaborations. Their work includes increasing MDPI’s visibility in scholarly communications, strengthening relationships with IOAP partners, and building trust with key stakeholders.
These efforts not only help researchers to publish their work openly and affordably but also reinforce MDPI’s position as a trusted leader in open access.
What are the benefits of MDPI’s IOAP?
For Authors: Researchers affiliated with IOAP partner institutions benefit from automatic discounts on APCs, Book Processing Charges (BPCs), JAMS, and Author Services across MDPI’s journals. The process is seamless as there is no need for codes or special applications. The publishing experience is smoother and more affordable, and centralized invoicing helps simplify the process, allowing authors to focus on their research rather than administration.
For Libraries: Participating libraries receive access to a dedicated institutional dashboard with live metadata on submissions from affiliated authors, past and present. They also benefit from flexible invoicing options (direct, collective, or prepayment) to help streamline administration, while clear, transparent agreements ensure that there are no hidden clauses or small print. Automated deposits into Institutional Repositories further reduce manual work, supporting libraries in their mission to advance open access and serve their research communities.
Inside MDPI
MDPI Self-citation study shows industry alignment
Earlier this month, Dr. Giulia Stefenelli and Dr. Enric Sayas published a thoughtful and transparent article on the ALPSP blog, presenting a self-citation analysis across MDPI’s 237 journals indexed in the Journal Citation Reports (JCR).
They found that MDPI's average self-citation rate in 2024 was 14.85%, well within industry norms and ranking 6th among the top ten publishers. Only 2.3% of MDPI journals were identified as outliers with high self-citation rates, compared to 4.7% among other leading publishers. An alternative approach, using weighted average by publication volume, shows MDPI’s self-citation rate rises from 14% to 19.7%, shifting our rank from 6th to 3rd. The study also shows that the impact of self-citation on journal quartile placement is minimal.
Read the full article on the ALPSP blog: https://blog.alpsp.org/2025/03/mdpi-self-citations-study-highlights.html
Why is this important?
As explained in the full article, the results “reinforce the fact that self-citations have minimal influence on MDPI journal rankings, emphasizing the integrity of editorial practices and the absence of any deliberate efforts to manipulate impact.”
Self-citation is a hot topic, and MDPI is sometimes unfairly singled out in this area. This analysis helps put some perspective to that narrative.
At MDPI, we are committed to transparency and to using data-driven insights to address common misconceptions about open access publishing. Our focus on self-citation reflects this commitment, and we plan to extend our efforts to other areas where the Gold OA model is often misunderstood.
About the authors
Dr. Giulia Stefenelli, Scientific Communications Lead, leverages her expertise in science communication, editorial processes, and Open Access (OA) promotion to address both institutional and country-specific challenges. She collaborates with teams across PR, Editorial Procedures, Institutional Partnerships, Research Integrity, AI and more, developing strategies to engage stakeholders, including policymakers, academics, and industry leaders. Her responsibilities include enhancing MDPI’s scientific network and promoting OA initiatives at events worldwide, supporting the efforts of various departments, and ensuring effective communication to both specialist and broader audiences.
Dr. Enric Sayas is a Business Analyst specializing in the integration of AI and Machine Learning in scientific publishing.
Within MDPI’s AI team, Enric combines his editorial expertise with his passion for AI to support the development of AI-driven solutions tailored to editorial needs, enhancing efficiency and improving decision-making.
Enric’s interests extend to data science methodologies applied to scientific publishing, as well as the broader impact of AI on open science, peer review, and the future of scientific publishing.
Coming Together for Science
Plants 2025: From Seeds to Food Security
Prof. Dr. Dilantha Fernando presenting at Plants 2025 in Barcelona, Spain.
The MDPI Conference Plants 2025: From Seeds to Food Security took place in Barcelona, Spain, from 31 March to 2 April 2025.
It was chaired by Editor-in-Chief of MDPI journal Plants (Q1 journal); Prof. Dr. Dilantha Fernando from the University of Manitoba, in Canada, and Section Editor-in-Chief of Plants; Dr. Fermín Morales from Instituto de Agrobiotecnología (IdAB) – CSIC, in Spain; and Prof. Dr. Oscar Vicente from Universitat Politècnica de València (UPV) in Spain.
The conference brought plant scientists together to discuss innovations in sustainable agriculture, crop improvement, and environmental conservation.
With the global population projected to reach 9.7 billion by 2050, the conference addressed key challenges such as food security, climate change, and sustainable agroecosystems through keynote talks and seven specialized sessions.
The conference gathered 111 attendees from 36 different countries, featuring 1 keynote speaker, 9 invited speakers, and 41 selected talks, along with 56 posters. The event received just over 200 submissions and 102 accepted abstracts.
From insightful talks, engaging poster sessions and engaging networking moments, Plants 2025 was a special experience. You can relive the highlights from the Plants 2025 conference here with our after movie!
Awards
Four awards were presented at the conclusion of the conference, sponsored by the journal Plants: two Best Poster Awards (€250 each) and two Best Oral Presentation Awards (€300 each).
Plants 2025 Conference Team
The Plants 2025 Conference was organized by colleagues from MDPI’s Conference Team: Ana Sanchis (Conference Manager), Cédric Spinnler (Senior Conference Organizer), Raquel Sellès (Conference Organizer) and Laura Perez (Conference Assistant).
Upcoming event
5–7 May 2025
The 2nd International Electronic Conference on Metals
Location: Online event (Central European Summer Time)
As one of the pillar technologies that support the development of modern society and metallurgy, IECME 2025 will present the state-of-the-art of Metallurgy and Metals.
Find more upcoming MDPI events here.
Closing Thoughts
Swedish consortium renews partnership with MDPI
I’m pleased to share that MDPI has renewed its national partnership with Sweden’s Bibsam Consortium. This is a continued commitment to advancing open access publishing and supporting Sweden’s vision for fully open research.
Under this renewed agreement, 22 leading institutions including KTH Royal Institute of Technology, Stockholm University, Linnaeus University, and Linköping University, will continue to benefit from MDPI’s IOAP. This provides discounts on APCs and a more streamlined, researcher-friendly publishing experience.
MDPI and Bibsam renew national agreement for Sweden
“With robust backing from national open science guidelines, Sweden’s open-access landscape is rapidly advancing,” says Becky Castellon, institutional partnerships manager at MDPI.
“In fact, fewer than 15% of all Swedish research outputs were locked behind paywalls in 2023. We are passionate about the positive impact our ongoing partnership with the Bibsam Consortium will have on Swedish research, paving the way for ground-breaking developments and a more inclusive, open scientific community. Through flexible solutions and tailored policies, we enable institutions to prioritize research, foster innovation, and enhance accessibility, driving the shift to full open access.”
Recent MDPI IOAP Consortium signings from 2025:
- The UK’s Jisc Consortium extended its national agreement, continuing support for more than 60 institutions across the UK.
- Switzerland’s CSAL (Consortium of Swiss Academic Libraries) renewed its agreement, continuing our collaboration with top institutions such as ETH Zurich and EPFL Lausanne.
- In Germany, we signed a new national agreement with ZB MED that includes over 100 universities and research institutions, with 78 institutions joining under a central or flat-fee model to simplify APC coverage.
Chief Executive Officer
MDPI AG
30 April 2025
Announcing the Award Committee for the 2024 Tu Youyou Award
We are honored to introduce the award committee for the 2024 Tu Youyou Award, composed of distinguished scientists from around the world whose research covers diverse areas of natural product chemistry, pharmacognosy, and drug discovery. Their broad expertise and pioneering contributions have significantly advanced medicinal and natural products research.
Through their collective insights, rigorous evaluation, the committee has carefully selected this year’s award recipients, recognizing exceptional achievements in the field.
We sincerely thank these distinguished scholars for their efforts and dedication to upholding the standards of the Tu Youyou Award. Below is the list of committee members. For more information about the Tu Youyou Award, please visit https://tuyouyouprize.org/.
Chair:
![]() Prof. Dr. A. Douglas Kinghorn Ohio State University, USA |
Prof. Dr. A. Douglas Kinghorn is a leading expert in pharmacognosy and natural products research. He is recognized for his key contributions to discovering bioactive compounds from plants, especially in anticancer, cancer chemopreventive, and substances with a sweet taste and taste-modifying agents. His prolific contributions include over 590 peer-reviewed works and book chapters and edited or co-edited 40 scientific volumes. |
![]() Prof. Angelo Fontana University of Naples “Federico II”, Italy |
Angelo Fontana is a Professor of Organic Chemistry at the University of Naples “Federico II” in Italy and serves as Director of the Institute of Biomolecular Chemistry at the National Research Council (CNR). His research focuses on bioactive small molecules derived from marine eukaryotes, with a particular interest on their pharmaceutical applications in immunology and oncology. He also explores their potential as molecular tools for probing and modulating complex biological systems. Prof. Fontana is a co-founder of BioSEArch SRL and has been recognized with numerous grants and honors, including the Apivita Award from the Phytochemical Society of Europe. |
![]() Prof. Binghe Wang Georgia State University, USA |
Prof. Binghe Wang’s lab works on drug design, drug delivery, click chemistry, chemical biology, new diagnostics, and gaseous signaling molecules such as carbon monoxide and hydrogen sulfide. His interdisciplinary research supports advances in cancer, infectious diseases, organ protection, inflammation, and other areas. |
![]() Dr. Diana Pinto University of Aveiro, Portugal |
Dr. Diana Pinto, an Associate Professor at the University of Aveiro, specializes in organic synthesis of bioactive heterocyclic compounds, sustainable catalysis (organo-, heterogeneous, and biocatalysis), and natural product research, including isolation, characterization, and total synthesis. |
![]() Prof. Hideaki Kakeya Kyoto University, Japan |
Prof. Hideaki Kakeya conducts cutting-edge research in chemical biology, high-throughput screening, and biosynthesis of bioactive natural products for system chemotherapy and other therapeutic applications. |
![]() Dr. RuAngelie Edrada-Ebel University of Strathclyde, UK |
Prof. RuAngelie Edrada-Ebel heads the Natural Products Metabolomics Group (NPMG), specializing in marine natural products discovery and metabolomics-driven drug development. A recognized expert in bioactive metabolites, she collaborates with industry and academia to address antimicrobial resistance and sustainable bioprospecting. She serves on the Editorial Board of Marine Drugs and holds two patents in the field. |
![]() Prof. Thomas Prisinzano University of Kentucky, USA |
Prof. Thomas Prisinzano combines medicinal and natural product chemistry to explore neurotransmitter systems and develop treatments for drug abuse and pain. He has received several prestigious awards, including the Innovator Award from the College on Problems of Drug Dependence. |
![]() Prof. Wei Li University of Tennessee Health Science Center, USA |
A distinguished professor and Director of the Drug Discovery Center, Prof. Wei Li is also the founder of SEAK Therapeutics, and the 2025 Chair-Elect of the Drug Discovery and Development Division of the American Society of Pharmacology and Experimental Therapeutics (ASPET). His work focuses on medicinal chemistry and small molecule drug discovery, with over 200 publications and 15 issued US patents. |
17 April 2025
Brain Sciences | Highly Cited Papers in 2023 in the Section “Neuropsychology”

The “Neuropsychology” Section of Brain Sciences (ISSN: 2076-3425) aims to bring together research on the relationship between the brain and human cognitive, emotional, and behavioral functions. Neuropsychological testing typically evaluates individual functioning in a number of areas, including sensorimotor functions, perception, attention, spatial construction, intelligence, executive functions, memory, language, motivation, emotion, and quality of life. Articles focusing on neuropsychological functions in both healthy and disordered states and across the lifespan are encouraged. Topic areas include both developmental (e.g., ADHD, dyslexia, and other learning disabilities) and adult studies (e.g., cognitive and affective consequences of stroke and traumatic brain injury, as well as progressive conditions, such as Alzheimer’s and Huntington’s disease). Contributions dealing with the development and testing of neuropsychological interventions are also encouraged. Original empirical research based on both clinical and experimental neuropsychological paradigms, as well as systematic reviews, meta-analyses, and theoretical articles, is envisaged. Case studies illustrating important questions about brain–behavior relationships will also be considered.
As all of the articles published in our journal are of an open access format, you have free and unlimited access to the full texts. We welcome you to read our most highly cited papers published in 2023, listed below.
1. “The Association between COVID-19 Related Anxiety, Stress, Depression, Temporomandibular Disorders, and Headaches from Childhood to Adulthood: A Systematic Review”
by Giuseppe Minervini, Rocco Franco, Maria Maddalena Marrapodi, Vini Mehta, Luca Fiorillo, Almir Badnjevi´c, Gabriele Cervino and Marco Cicciù
Brain Sci. 2023, 13(3), 481; https://doi.org/10.3390/brainsci13030481
Available online: https://www.mdpi.com/2076-3425/13/3/481
2. “GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach”
by Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L. Sensi and Fabrizio Schifano
Brain Sci. 2023, 13(11), 1503; https://doi.org/10.3390/brainsci13111503
Available online: https://www.mdpi.com/2076-3425/13/11/1503
3. “Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review”
by Mariana Campello de Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi, Julio Torales, Antonio Ventriglio, Henrique Silva Bombana, Vilma Leyton, Cintia de Azevedo-Marques Périco, André Brooking Negrão, André Malbergier et al.
Brain Sci. 2023, 13(7), 990; https://doi.org/10.3390/brainsci13070990
Available online: https://www.mdpi.com/2076-3425/13/7/990
4. “Brain Correlates of Eating Disorders in Response to Food Visual Stimuli: A Systematic Narrative Review of FMRI Studies”
by Alessia Celeghin, Sara Palermo, Rebecca Giampaolo, Giulia Di Fini, Gabriella Gandinoand and Cristina Civilotti
Brain Sci. 2023, 13(3), 465; https://doi.org/10.3390/brainsci13030465
Available online: https://www.mdpi.com/2076-3425/13/3/465
5. “Enhanced Skills Training in Affective and Interpersonal Regulation (ESTAIR): A New Modular Treatment for ICD-11 Complex Posttraumatic Stress Disorder (CPTSD)”
by Thanos Karatzias, Edel Mc Glanaghy and Marylene Cloitre
Brain Sci. 2023, 13(9), 1300; https://doi.org/10.3390/brainsci13091300
Available online: https://www.mdpi.com/2076-3425/13/9/1300
6. “Neurocognitive Deficits in First-Episode and Chronic Psychotic Disorders: A Systematic Review from 2009 to 2022”
by Nadja Tschentscher, Christian F. J. Woll, Julia C. Tafelmaier, Dominik Kriesche, Julia C. Bucher, Rolf R. Engel and Susanne Karch
Brain Sci. 2023, 13(2), 299; https://doi.org/10.3390/brainsci13020299
Available online: https://www.mdpi.com/2076-3425/13/2/299
2 April 2025
MDPI INSIGHTS: The CEO's Letter #21 - Annual Report, Swiss Consortium, IWD, ICARS, Serbia

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Releases 2024 Annual Achievements Report
I’m pleased to share the release of MDPI’s 2024 Annual Achievements Report, which reflects our commitment to efficiency, transparency, and excellence in scholarly communication. The report showcases key themes related to our growth (highlighting our workforce expansion, new offices, journal milestones), excellence (editorial and publishing advancements), people (talent development and training), and community (partnerships, conferences, and outreach).
MDPI continues to build connections and drive scientific progress
Our mission remains clear: to support researchers worldwide by delivering an efficient, high-quality publishing experience while strengthening the global Open Access (OA) movement.
Advancing Open Access: A Global Knowledge Hub
In 2024, we published 238,000 peer-reviewed OA articles, reaching over 25 million downloads. This reinforces MDPI’s role as a global knowledge hub, breaking down barriers to access and ensuring that high-quality research is freely available to everyone. As part of the OA movement, we are actively democratizing knowledge, making scientific advancements accessible to researchers, policymakers, educators, and the public, without the restrictions of traditional paywalls.
Expanding our Workforce and Strengthening Research Integrity
Our global presence grew in 2024 with the opening of a new Seoul office, and our workforce expanded to 6,650 staff across 21 offices. This reflects our continued growth mindset and investment in global accessibility. We also continued to take a proactive stance on our commitment to research integrity, tripling our team in this area and joining STM’s Integrity Hub and United2Act. This means more rigorous quality control, stronger safeguards, and collaboration with global initiatives to detect and combat unethical publishing practices at an industry level. Our growth is about reinforcing our role as a trusted, ethical, and accessible publishing platform for researchers worldwide.
Growing Partnerships and Impact in Scholarly Communication
MDPI’s partnerships continue to thrive, with over 900 institutional collaborations, including a landmark agreement with ZB MED in Germany, covering more than 100 universities. Additionally, more than 90% of evaluated MDPI journals have been accepted into Web of Science, including 60 new acceptances in 2024, with nearly 300 journals expected to receive a Journal Impact Factor in 2025. In the same period, 37 MDPI journals were accepted into Scopus, bringing our total indexed titles to 306. Most importantly, 95% of authors rate their experience with MDPI as excellent or good – an achievement that underscores our dedication to serving the research community.
I encourage you to read through our Annual Report, which highlights these milestones and our vision for the future. Thank you for being part of MDPI’s journey in advancing open science.
Impactful Research
MDPI Renews Partnership with CSAL to Support Swiss Universities
I am pleased to announce the renewal of our partnership with the Consortium of Swiss Academic Libraries (CSAL) for 2025. This extension reinforces MDPI's dedication to advancing open science through transparency, efficiency, and collaboration.
Our renewed agreement with CSAL strengthens support for Swiss universities, ensuring that gold open access publishing remains both accessible and affordable for researchers across Switzerland. Among the institutions participating in this agreement are ETH Zurich and EPFL Lausanne, along with 20 other leading institutions, further expanding the reach and impact of our collaborative efforts.
To date, over 3.9 million researchers have published their findings in MDPI journals, a testament to our role in enhancing Switzerland's position as a hub for university education and research.
Inside MDPI
Celebrating International Women's Day: Accelerating Action
In honour of International Women's Day, MDPI embraced the theme “Accelerate Action,” a global call to advance women's progress by implementing effective strategies and resources. As part of our commitment, we highlighted how open access publishing empowers female voices in research and academia.
Throughout March, we featured original blogs authored by MDPI’s female contributors, showcasing the successes of our journals and employees, and addressing pressing topics such as women's health.
“Open Access supports women in education”
Women Accelerating Action Outside of MDPI
MDPI employee Ana Zdravkovic is accelerating action outside of her MDPI role as a Production Assistant. Working with like-minded women at the award-winning Belgrade-based organization UZOR OsnaŽene (meaning ‘empowered women’), they identify serious flaws in cybersecurity, and help protect women and children against online predators by providing evidence to improve legislation and laws around cyber-attacks.
In this article, we interview Ana, celebrating the important and inspiring work that she and the organisation do.
How Open Access Supports Women in Education
Every day, women and girls face barriers in education or career progression. This is caused by a range of factors, including social expectations, poverty, and poor infrastructure.
Quality opportunities and participation in the education system by women is essential to achieving equality and fulfilling their human rights.
Here, we examine how Open Access supports women in education by removing barriers and ensuring that vital research is accessible.
Recent Advancements in Research on Endometriosis
March is Endometriosis Action Month. Endometriosis is a medical condition affecting women and young girls of reproductive age, often causing symptoms such as severe pelvic pain, irregular periods, and infertility.
More research on endometriosis is still urgently needed.
This research will help develop efficient diagnoses and better treatment for those struggling with the condition.
In this article, we explore what endometriosis is and discuss the latest research advancements on the disease.
We also curated a selection of MDPI journals, articles, and Special Issues focusing on gender equity, women in the workplace, and women’s health. Find out more about these by visiting our IWD – Accelerate Action landing page.
As I reflect on the month of March and International Women’s Day, I would like to take a moment to recognize and thank all of the incredible women at MDPI for your dedication to democratizing knowledge and shaping open access. Your contributions are invaluable, and they continue to shape the future of MDPI.
Coming Together for Science
The International Conference on Advanced Remote Sensing (ICARS 2025)
The International Conference on Advanced Remote Sensing (ICARS 2025) took place from 26–28 March 2025, in Barcelona, Spain. It was chaired by Prof. Dr. Fabio Tosti from the Faringdon Research Centre for Non-Destructive Testing and Remote Sensing (UK), Prof. Dr. Andrea Benedetto from University Roma Tre (Italy), and Prof. Dr. Luis Ángel Ruiz from Universitat Politècnica de València (UPV, Spain).
Over three days, the conference explored innovations in Earth and environmental sciences, engineering advancements, and practical applications in biological and agricultural fields.
I am pleased to share that the 1st edition of ICARS 2025 was a great success, with 133 attendees out of 146 registrations. The event featured 43 short talks, 64 posters, and 103 accepted abstracts, along with nine keynote speakers and a major panel with five expert panellists.
Over 60 attendees joined the conference dinner, and the event received outstanding feedback.
The main goal of ICARS2025 was to cover how advanced remote sensing technologies are transforming our approach to global challenges.
Awards
Four awards were presented at the conclusion of the conference, sponsored by the journal Remote Sensing: Best Poster Award (€400), Best Oral Presentation Award (€400), and two Early Career Researcher Awards (1st prize: €600 and 2nd prize: €200).
Thank you to our Partnering Societies
We are grateful for the support of our four partnering societies and nine media partners, who played an important role in promoting the conference. Special thanks to our partnering societies: the European Federation of Geologists (EFG), Geoscience Energy Society of Great Britain (GESGB), Asociación Española de Teledetección (AET) – the Spanish Association of Remote Sensing, and the International Society for Digital Earth (ISDE).
Upcoming In-Person Event
31 March–2 April 2025
Plants 2025: From Seeds to Food Security
Location: Barcelona, Spain
This event will gather plant scientists to discuss the latest research on how to feed a growing population while maintaining a sustainable agro-ecosystem.
Find more upcoming MDPI events here.
Closing Thoughts
MDPI Serbia Salon 2025: A Gathering of Academic Excellence
On Tuesday, 18 March, we successfully concluded our first MDPI Serbia Salon in Belgrade. This event provided a great opportunity to showcase MDPI’s achievements, strengthen connections with the Serbian academic community, and highlight our role as the largest publisher in Serbia. We were honoured to welcome Prof. Dr. Sergej M. Ostojić, Editor-in-Chief of MDPI journal Clinical Bioenergetics, as a guest speaker.
Over the past five years, MDPI has experienced continuous growth in Serbia, with an increasing number of publications, an expansion of Editorial Board memberships, and a greater number of active peer reviewers. The Salon allowed us to express our thanks to the Serbian research community while gathering feedback from attendees representing several major universities.
Discussion topics
As part of the event, I delivered an opening speech highlighting MDPI’s achievements and direction.
The event featured presentations from MDPI colleagues, including discussions on open science, publishing ethics, and our achievements in Serbia.
A special thank-you to all our MDPI presenters, panellists, and organizers who made his event a success. I hope the MDPI Serbia Salon becomes a tradition for years to come, creating connections within the Serbian research community.
Visit to the Science Fund of Serbia and The Ministry of Science
During my visit to Belgrade, I had the opportunity to join my colleagues Emir Ramadani (Operations Manager) and Nevena Blagojev (Journal Relations Manager) in meetings with the Science Fund of Serbia and the Ministry of Science, where we received strong support for our work in Serbia.
Both organizations highly value our presence in and commitment to Serbia, where we employ over 640 staff across our two offices in Belgrade and Novi Sad. We take great pride in creating job opportunities and supporting the community in Serbia.
“There’s a lot of exciting activity happening in MDPI Serbia”
Speaking with our Serbian Colleagues
Finally, I had the opportunity to speak with our Serbian colleagues about our initiatives to expand and to improve our marketing & communication and public relations activities.
It was great to have an open discussion with colleagues – both in person and with the hundreds who joined online.
This visit to Belgrade had been a long time coming for me. Serbia is our largest operation in Europe and there’s a lot of exciting activity happening in MDPI Serbia, including the launch of a new office floor in Novi Sad and the growth and expansion of our teams.
I look forward to returning soon and continuing to support our colleagues across our Serbian offices.
Chief Executive Officer
MDPI AG
1 April 2025
Meet us at the 11th Congress of the European Academy of Neurology, 21–24 June 2025, Helsinki, Finland

MDPI will be attending the 11th Congress of the European Academy of Neurology, which will be held in Helsinki, Finland, from 21 to 24 June 2025. The EAN Congress 2025 is organized by the European Academy of Neurology. Its exciting overarching theme of neurology within society sets the scene for an unforgettable congress and is highly relevant to our practice as neurologists, given our crucial role as clinicians—and in many cases neuroscientists—in addressing the huge burden of neurological disorders. To have an impact, we must work with many other stakeholders and specialties, and we look forward to welcoming many of them to the home of neurology in 2025. As usual, the overarching theme will serve as a common thread throughout all the invited content of our congress, from workshops to plenary sessions.
The following MDPI journals will be represented:
- Brain Sciences;
- JCM;
- CTN;
- Neurology International;
- Neuroglia;
- Cells;
- Diagnostics;
- Neurosci;
- Psychiatry International;
- Antioxidants;
- Biomolecules;
- Genes;
- IJTM;
- Vaccines.
If you plan to attend the conference, please visit our booth #E48. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.ean.org/congress2025.
1 April 2025
Recruiting Volunteer Reviewers for Brain Sciences
Peer reviewing is an essential part of the publication process, ensuring that Brain Sciences (ISSN: 2076-3425) maintains its high standards for the quality of published papers. We wish to recruit expert reviewers to help uphold the quality and efficiency of Brain Sciences.
To qualify as a reviewer, applicants must have published around eight papers related to the topics covered by Brain Sciences in the last 5 years and hold a Ph.D. degree. You may check “Peer Review” in the MDPI Editorial Process for details related to reviewers by using the following link: https://www.mdpi.com/editorial_process. For example, reviewers should hold no conflicts of interest with any of the authors, reviewers should hold work for an official and recognized academic institution, etc.
We will extend the following benefits to reviewers:
- Reviewers will receive a discount voucher code based on review quality;
- Reviewers will be included in the journal’s annual acknowledgment of reviewers (example: https://www.mdpi.com/about/announcements/10579);
- Reviewers will be considered for the Brain Sciences Outstanding Reviewer Award, details of which can be found at https://www.mdpi.com/journal/brainsci/awards/2937;
- Reviewers can build their profile on Publons and have their reviewing activity automatically added for participating journals, and Publons profiles can be integrated into ORCID.
For more information, please visit the following link: https://www.mdpi.com/reviewers.
If you are interested in this position, please submit your application at https://susy.mdpi.com/volunteer/journals/review.
We hope that you will join our team of reviewers. After your registration is approved, you will see a list of manuscripts for recruiting reviewers.
If you have any other questions, please contact the Brain Sciences Editorial Office. We look forward to hearing from you.
20 March 2025
Brain Sciences | Highly Cited Papers in 2023 in the “Sensory and Motor Neuroscience” Section

The “Sensory and Motor Neuroscience” Section in Brain Sciences (ISSN: 2076-3425) brings together research on the functioning of our sensory and movement systems. The Section explores applications of the anatomical and functional neurobiology of motor, sensorimotor, vestibular, and somatosensory systems across the lifespan and in aging.
As all of the articles published in our journal are of an open access format, you have free and unlimited access to the full texts. We welcome you to read our most highly cited papers published in 2023, listed below:
1. “Artificial Intelligence Frameworks to Detect and Investigate the Pathophysiology of Spaceflight Associated Neuro-Ocular Syndrome (SANS)”
by Joshua Ong, Ethan Waisberg, Mouayad Masalkhi, Sharif Amit Kamran, Kemper Lowry, Prithul Sarker, Nasif Zaman, Phani Paladugu, Alireza Tavakkoli and Andrew G. Lee
Brain Sci. 2023, 13(8), 1148; https://doi.org/10.3390/brainsci13081148
Available online: https://www.mdpi.com/2076-3425/13/8/1148
2. “Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows”
by Claudia Vinciguerra, Liliana Bevilacqua, Antonino Lupica, Federica Ginanneschi, Giuseppe Piscosquito, Nicasio Rini, Alessandro Rossi, Paolo Barone, Filippo Brighina and Vincenzo Di Stefano
Brain Sci. 2023, 13(9), 1286; https://doi.org/10.3390/brainsci13091286
Available online: https://www.mdpi.com/2076-3425/13/9/1286
3. “Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy”
by Vincenzo Di Stefano, Francesco Prinzi, Marco Luigetti, Massimo Russo, Stefano Tozza, Paolo Alonge, Angela Romano, Maria Ausilia Sciarrone, Francesca Vitali, Anna Mazzeo et al.
Brain Sci. 2023, 13(5), 805; https://doi.org/10.3390/brainsci13050805
Available online: https://www.mdpi.com/2076-3425/13/5/805
4. “Low Levels of Adenosine and GDNF Are Potential Risk Factors for Parkinson’s Disease with Sleep Disorders”
by Li Wang, Zheng Gao, Gang Chen, Deqin Geng and Dianshuai Gao
Brain Sci. 2023, 13(2), 200; https://doi.org/10.3390/brainsci13020200
Available online: https://www.mdpi.com/2076-3425/13/2/200
5. “Resolvin D2 Reduces Chronic Neuropathic Pain and Bone Cancer Pain via Spinal Inhibition of IL-17 Secretion, CXCL1 Release and Astrocyte Activation in Mice”
by Jun Pang, Pengfei Xin, Ying Kong, Zhe Wang and Xiaopeng Wang
Brain Sci. 2023, 13(1), 152; https://doi.org/10.3390/brainsci13010152
Available online: https://www.mdpi.com/2076-3425/13/1/152
4 March 2025
Brain Sciences | Highly Cited Papers from 2023 in the “Neuropsychiatry” Section

The “Neuropsychiatry” Section gathers the best available scientific evidence to guide clinical practice in the treatment of psychiatric illnesses. Submissions of original articles and reviews which advance our understanding of the etiology, course, and treatment of psychiatric illnesses are invited. Papers reporting sound evidence-based practices which provide safeguards against reporting bias and promote the reproducibility of study procedures and the replicability of results, for example through the preregistration of study hypotheses, are especially welcome.
As all of the articles published in our journal are of an open access format, you have free and unlimited access to the full texts. We invited you to read our most highly cited papers published in 2023, which are listed below.
1. “Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review”
by Ahmed Hasbi, Bertha K. Madras and Susan R. George
Brain Sci. 2023, 13(2), 325; https://doi.org/10.3390/brainsci13020325
Available online: https://www.mdpi.com/2076-3425/13/2/325
2. “The Role of Brain-Derived Neurotrophic Factor (BDNF) in Diagnosis and Treatment of Epilepsy, Depression, Schizophrenia, Anorexia Nervosa and Alzheimer’s Disease as Highly Drug-Resistant Diseases: A Narrative Review”
by Aleksandra Gliwińska, Justyna Czubilińska-Łada, Gniewko Więckiewicz, Elżbieta Świętochowska, Andrzej Badeński, Marta Dworak and Maria Szczepańska
Brain Sci. 2023, 13(2), 163; https://doi.org/10.3390/brainsci13020163
Available online: https://www.mdpi.com/2076-3425/13/2/163
3. “Application of Antipsychotic Drugs in Mood Disorders”
by Janusz K. Rybakowski
Brain Sci. 2023, 13(3), 414; https://doi.org/10.3390/brainsci13030414
Available online: https://www.mdpi.com/2076-3425/13/3/414
4. “Measuring Social Camouflaging in Individuals with High Functioning Autism: A Literature Review”
by Ivan Mirko Cremone, Barbara Carpita, Benedetta Nardi, Danila Casagrande, Rossella Stagnari, Giulia Amatori and Liliana Dell’Osso
Brain Sci. 2023, 13(3), 469; https://doi.org/10.3390/brainsci13030469
Available online: https://www.mdpi.com/2076-3425/13/3/469
5. “Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs—A Review”
by Antonino Messina, Carmen Concerto, Alessandro Rodolico, Antonino Petralia, Filippo Caraci and Maria Salvina Signorelli
Brain Sci. 2023, 13(6), 957; https://doi.org/10.3390/brainsci13060957
Available online: https://www.mdpi.com/2076-3425/13/6/957
6. “Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders”
by Javier Pagonabarraga, Cecilio Álamo, Mar Castellanos, Samuel Díaz and Sagrario Manzano
Brain Sci. 2023, 13(2), 318; https://doi.org/10.3390/brainsci13020318
Available online: https://www.mdpi.com/2076-3425/13/2/318
7. “Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders”
by Marcin Siwek, Krzysztof Wojtasik-Bakalarz, Anna Julia Krupa and Adrian Andrzej Chrobak
Brain Sci. 2023, 13(3), 397; https://doi.org/10.3390/brainsci13030397
Available online: https://www.mdpi.com/2076-3425/13/3/397
8. “Long-Term Lithium Therapy and Thyroid Disorders in Bipolar Disorder: A Historical Cohort Study”
by Boney Joseph, Nicolas A. Nunez, Vanessa Pazdernik, Rakesh Kumar, Mehak Pahwa, Mete Ercis, Aysegul Ozerdem, Alfredo B. Cuellar-Barboza, Francisco Romo-Nava, Susan L. McElroy et al.
Brain Sci. 2023, 13(1), 133; https://doi.org/10.3390/brainsci13010133
Available online: https://www.mdpi.com/2076-3425/13/1/133
9. “Epigenetic Targets in Schizophrenia Development and Therapy”
by Agnieszka Wawrzczak-Bargieła, Wiktor Bilecki and Marzena Maćkowiak
Brain Sci. 2023, 13(3), 426; https://doi.org/10.3390/brainsci13030426
Available online: https://www.mdpi.com/2076-3425/13/3/426
10. “Oxidative Stress Biomarkers among Schizophrenia Inpatients”
by Magdalena Więdłocha, Natalia Zborowska, Piotr Marcinowicz, Weronika Dębowska, Marta Dębowska, Anna Zalewska, Mateusz Maciejczyk, Napoleon Waszkiewicz and Agata Szulc
Brain Sci. 2023, 13(3), 490; https://doi.org/10.3390/brainsci13030490
Available online: https://www.mdpi.com/2076-3425/13/3/490
11. “Research and Diagnostic Algorithmic Rules (RADAR) and RADAR Plots for the First Episode of Major Depressive Disorder: Effects of Childhood and Recent Adverse Experiences on Suicidal Behaviors, Neurocognition and Phenome Features”
by Michael Maes and Abbas F. Almulla
Brain Sci. 2023, 13(5), 714; https://doi.org/10.3390/brainsci13050714
Available online: https://www.mdpi.com/2076-3425/13/5/714
12. “Comorbidity and Overlaps between Autism Spectrum and Borderline Personality Disorder: State of the Art”
by Liliana Dell’Osso, Ivan Mirko Cremone, Benedetta Nardi, Valeria Tognini, Lucrezia Castellani, Paola Perrone, Giulia Amatori and Barbara Carpita
Brain Sci. 2023, 13(6), 862; https://doi.org/10.3390/brainsci13060862
Available online: https://www.mdpi.com/2076-3425/13/6/862
13. “Regulatory Clearance and Approval of Therapeutic Protocols of Transcranial Magnetic Stimulation for Psychiatric Disorders”
by Gonçalo Cotovio, Fabiana Ventura, Daniel Rodrigues da Silva, Patrícia Pereira and Albino J. Oliveira-Maia
Brain Sci. 2023, 13(7), 1029; https://doi.org/10.3390/brainsci13071029
Available online: https://www.mdpi.com/2076-3425/13/7/1029
14. “Rumination as a Transdiagnostic Phenomenon in the 21st Century: The Flow Model of Rumination”
by Stephanie M. Y. Wong, Eric Y. H. Chen, Michelle C. Y. Lee, Y. N. Suen and Christy L. M. Hui
Brain Sci. 2023, 13(7), 1041; https://doi.org/10.3390/brainsci13071041
Available online: https://www.mdpi.com/2076-3425/13/7/1041
15. “Lethal Lust: Suicidal Behavior and Chemsex—A Narrative Review of the Literature”
by Martina Strasser, Theresa Halms, Tobias Rüther, Alkomiet Hasan and Marcus Gertzen
Brain Sci. 2023, 13(2), 174; https://doi.org/10.3390/brainsci13020174
Available online: https://www.mdpi.com/2076-3425/13/2/174
16. “Breathwork Interventions for Adults with Clinically Diagnosed Anxiety Disorders: A Scoping Review”
by Blerida Banushi, Madeline Brendle, Anya Ragnhildstveit, Tara Murphy, Claire Moore, Johannes Egberts and Reid Robison
Brain Sci. 2023, 13(2), 256; https://doi.org/10.3390/brainsci13020256
Available online: https://www.mdpi.com/2076-3425/13/2/256
17. “Depression Is Associated with an Increased Risk of Subsequent Cancer Diagnosis: A Retrospective Cohort Study with 235,404 Patients”
by Hannah Mössinger and Karel Kostev
Brain Sci. 2023, 13(2), 302; https://doi.org/10.3390/brainsci13020302
Available online: https://www.mdpi.com/2076-3425/13/2/302
18. “Novel Compounds in the Treatment of Schizophrenia—A Selective Review”
by Evangelia Maria Tsapakis, Kalliopi Diakaki, Apostolos Miliaras and Konstantinos N. Fountoulakis
Brain Sci. 2023, 13(8), 1193; https://doi.org/10.3390/brainsci13081193
Available online: https://www.mdpi.com/2076-3425/13/8/1193
19. “Abnormalities of EEG Functional Connectivity and Effective Connectivity in Children with Autism Spectrum Disorder”
by Xinling Geng, Xiwang Fan, Yiwen Zhong, Manuel F. Casanova, Estate M. Sokhadze, Xiaoli Li and Jiannan Kang
Brain Sci. 2023, 13(1), 130; https://doi.org/10.3390/brainsci13010130
Available online: https://www.mdpi.com/2076-3425/13/1/130
20. “The Comorbidity of Depression and Anxiety Symptoms in Tinnitus Sufferers: A Network Analysis”
by Xuemin Chen, Lei Ren, Xinmiao Xue, Ning Yu, Peng Liu, Weidong Shen, Hanwen Zhou, Ben Wang, Jingcheng Zhou, Shiming Yang et al.
Brain Sci. 2023, 13(4), 583; https://doi.org/10.3390/brainsci13040583
Available online: https://www.mdpi.com/2076-3425/13/4/583
21. “The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review”
by Muhammad Youshay Jawad, Saleha Qasim, Menglu Ni, Ziji Guo, Joshua D. Di Vincenzo, Giacomo d’Andrea, Aniqa Tabassum, Andrea Mckenzie, Sebastian Badulescu, Iria Grande et al.
Brain Sci. 2023, 13(6), 909; https://doi.org/10.3390/brainsci13060909
Available online: https://www.mdpi.com/2076-3425/13/6/909
27 February 2025
More than 300 MDPI Journals Indexed in Web of Science
MDPI is pleased to share a significant milestone in its mission to advance scholarly research and promote the dissemination of knowledge—300+ MDPI journals are now indexed in Web of Science (WoS). This milestone highlights the global recognition, interdisciplinary impact and enhanced visibility of our journals. It also reflects our adherence to rigorous editorial standards, scientific integrity, and our mission to foster open scientific exchange in all forms, across all disciplines.

To explore the full list of our journals indexed in WoS, please visit https://www.mdpi.com/about/journals/wos. Beyond expanding the coverage of our publications in the leading academic databases, we are dedicated to ensuring that our journals are included in as many scope-specific databases as possible. This increases the visibility of our authors’ work and extends the reach of their significant data.
This milestone would not have been possible without the efforts and expertise of our academic editors, reviewers and authors. Their commitment and collaboration have been instrumental in creating an inclusive, accessible, and impactful publishing platform. We also extend our gratitude to the global research community for their trust as we continue to break new ground in academic publishing. This milestone is not just a celebration of MDPI’s progress but also recognition of the collective strides made by researchers worldwide.
As we celebrate this remarkable accomplishment, MDPI remains steadfast in its commitment to open access publishing and ensuring that high-quality research reaches and inspires a global audience.